Tag: biosimilars billing
Biosimilars are billed differently than generics under Medicare Part B. Each has its own HCPCS code and payment rate based on its ASP plus 6% of the reference product’s price. This system encourages biosimilar entry but doesn’t strongly incentivize switching. Learn how billing works and why adoption remains low in the U.S.
Medications
Archives
Recent-posts
Inactive Ingredients in Generic Medications: What You Need to Know
Nov, 29 2025
Top 10 Online Pharmacy Alternatives to CanadaDrugsDirect for Affordable Medication
Dec, 19 2024
Goldenseal and Metformin Interaction Risks for Blood Sugar Control
Dec, 30 2025
Crossover Trial Design: How Bioequivalence Studies Are Structured
Dec, 15 2025
Caverta (Sildenafil) 2025: Uses, Safe Dose, Side Effects, and Buying Guide
Aug, 29 2025